NeuroPace Inc (NPCE)
8.49
+0.53
(+6.66%)
USD |
NASDAQ |
May 10, 16:00
8.49
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Debt to Equity Ratio: 2.758 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.758 |
| September 30, 2023 | 3.416 |
| June 30, 2023 | 2.584 |
| March 31, 2023 | 1.959 |
| December 31, 2022 | 1.522 |
| September 30, 2022 | 1.197 |
| June 30, 2022 | 0.9644 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.7977 |
| December 31, 2021 | 0.6782 |
| September 30, 2021 | 0.6068 |
| June 30, 2021 | 0.5566 |
| March 31, 2021 | -0.3398 |
| December 31, 2020 | -0.3576 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.3576
Minimum
Dec 2020
3.416
Maximum
Sep 2023
1.257
Average
0.9644
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Ainos Inc | 0.2439 |
| OpGen Inc | 3.437 |
| Zomedica Corp | 0.00 |
| LENSAR Inc | 0.00 |
| Eargo Inc (DELISTED) | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 107.65M |
| Total Liabilities (Quarterly) | 87.00M |
| Shareholders Equity (Quarterly) | 20.65M |
| Current Ratio | 5.713 |
| Net Debt Paydown Yield | -0.35% |